Embolic Protection Devices Market Size, Share, Growth Analysis, By Type(Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices), By Material(Nitinol, Polyurethane), By Indication(Percutaneous Coronary Intervention, Carotid Artery Diseases, Saphenous Vein Graft Disease, Transcatheter Aortic Valve Replacement), By Application(Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases), By End User(Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2683 | Region: Global | Published Date: October, 2024
Pages: 157 |Tables: 62 |Figures: 75

Embolic Protection Devices Market Insights

Global Embolic Protection Devices Market size was valued at USD 554.55 million in 2022 and is poised to grow from USD 604.88 million in 2023 to USD 1146.41 million by 2031, growing at a CAGR of 8.32% during the forecast period (2024-2031).
 
The growing number of patients suffering from cardiovascular disease is driving the embolic protection devices market growth. The development of minimally invasive procedures due to shorter recovery time and lower complications as compared to conventional surgical procedures is driving the market growth. Technological advancements and advancements in embolic protection devices are expected to boost the market outlook over the next decade.  
 
The rising demand for embolic protection devices to mitigate the risks of embolization during interventions due to the increasing prevalence of cardiovascular diseases such as atherosclerosis and coronary artery disease will stimulate the growth of the embolic protection devices market during the forecast period. Furthermore, the heightened emphasis on reducing post-procedural complications and hospital stays has accelerated the adoption of embolic protection devices as it assists in preventing embolic events, thereby contributing to the market growth.  
Moreover, increasing adoption of minimally invasive techniques across various medical specialties has augmented the demand for embolic protection devices. These devices are integral to preserving patient safety during complex procedures like angioplasty, stenting, and transcatheter aortic valve replacement. Apart from this, numerous technological advancements, including improved filter designs and material innovation, that enhance performance and patient outcomes, are propelling the market growth. 

US Embolic Protection Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot

Global Market Size

USD 0.51 Billion

Largest Segment

Distal Occlusion Filters

Fastest Growth

Distal Occlusion Filters

Growth Rate

8.2% CAGR

Global Embolic Protection Devices Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Embolic Protection Devices Market Segmental Analysis

Global Embolic Protection Devices Market is segmented by Type, Material, Indication, Application, End User, and Region. Based on Type, the market is segmented into Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices. Based on Material, the market is segmented into Nitinol, Polyurethane. Based on Indication, the market is segmented into Percutaneous Coronary Intervention, Carotid Artery Diseases, Saphenous Vein Graft Disease, Transcatheter Aortic Valve Replacement, Other Indications. Based on Application, the market is segmented into Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. 

Analysis by Type 

As per embolic protection devices market outlook, distal filter devices are the dominant segment due to their widespread application, ease of use, and ability to maintain blood flow during procedures. Embolic protection devices are extensively used due to their effectiveness in capturing embolic debris during the minimally invasive cardiovascular procedures. These devices work by filtering the emboli while maintaining blood flow and enables the carotid artery stenting. Their ease of use, compatibility with diverse catheter sizes, and potential to provide actual-time emboli capture make them a favored preference among healthcare experts. Technological advances, which include the progressed filters for more flexibility and biocompatibility, production, retain to drive their adoption. 

Distal occlusion devices are experiencing notable growth, particularly in niche applications where blood flow cessation is critical. Remote closure devices work to capture and remove embolic debris by temporarily stopping blood flow below the treatment site. These devices are effective in procedures where complete cessation of blood flow is required for adequate emboli management, such as during high-risk interventions. Although they are less commonly used compared to devices of remote filters, though offers good protection in specific cases with physical or structural complications minimizes the impact of remote filter devices. New trends with advances in occlusion balloon materials and delivery systems including enhancing the reliability and safety of these devices. 

Analysis by Material 

As per embolic protection devices market analysis, nitinol dominates the market due to its unparalleled mechanical properties and advanced mechanical performance. Nitinol is a leading segment in the embolic protection devices market due to its key role in improving flexibility, stability and accuracy during treatment. The widespread use of nitinol in filtering devices and high-performance guidewires ensures its dominance, especially in high-volume procedures such as transcatheter aortic valve replacement (TAVR) and carotid in artery stenting.  Nitinol, a shape-memory alloy of nickel and titanium, plays an important role in embolic protection devices (EPDs) due to its unique properties of hyperelasticity and biocompatibility. These properties enable nitinol-based devices to repair vascular anatomy. 

Polyurethane is the fastest growing segment, driven by the widespread use in device coatings and structural components aimed at improving biocompatibility and reducing complications. The demand for enhanced safety features and longer-lasting devices has accelerated the adoption of polyurethane, particularly in emerging markets where cost-effective and reliable solutions are critical. Polyurethane is rapidly gaining traction as manufacturers improve the patient safety and mechanical performance priority. The versatile polymer polyurethane is widely used in the embolic protection devices market, especially for the coatings and components requiring biocompatibility and durability. Its use in device filters and sheaths ensures the optimal blood flow, reduces the risk of thrombosis and reduces tissue damage during use. 

Global Embolic Protection Devices Market By Type (%)

To get detailed analysis on other segments, Request For Free Sample Report

Embolic Protection Devices Market Regional Insights

As per embolic protection devices market outlook, North America is the dominant region in embolic protective devices market, mainly due to advanced healthcare, high prevalence of cardiovascular diseases and high adoption of minimally invasive procedures. The US especially leads the market with the presence of key players such as Boston Scientific and Abbott Laboratories, who constantly introduce new EPDs. Furthermore, they focused on reducing the burden of cardiovascular diseases driving high demand for EPDs of transcatheter aortic valve replacement (TAVR) procedures and other interventional surgeries. Government policies also contribute to the dominance of the market in the United States. 

Asia-Pacific is the fastest growing region in the embolic protection devices market, driven by rising healthcare costs, increasing heart health awareness and increasing prevalence of vascular diseases among the elderly population. Emerging countries such as China, India and Japan are witnessing a surge in minimally invasive procedures, spurred by improvements in healthcare infrastructure and access to advanced medical technologies. Government initiatives encourage the modernization of healthcare facilities and expansion of the medical tourism in countries like India and Thailand are also increasing the demand for EPDs. Furthermore, the cost-effective manufacturing environment in Asia Pacific has attracted worldwide players to establish production facilities and enhance distribution networks inside the region. 

Global Embolic Protection Devices Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Embolic Protection Devices Market Dynamics

Embolic Protection Devices Market Drivers 

Increasing Incidence of Cardiovascular Diseases and Atherosclerosis 

  • Increasing incidence of cardiovascular diseases, vascular diseases, such as stroke, atherosclerosis and myocardial infarction is the major driver of the embolic protection devices industry. These conditions often cause emboli, which can damage the blood and cause serious complications. EPDs are important in preventing embolism during interventions such as angioplasty and transcatheter aortic valve replacement (TAVR). The aging global population, which is prone to muscle dysfunction, further increases the demand for these devices.  

Advances in Minimally Invasive Techniques 

  • The transition to minimally invasive surgical techniques has increased the adoption of embolic protection devices. Minimally invasive surgery shortens patient recovery time, reduces surgical risks, and improves surgical accuracy. EPDs are essential in such cases to capture and remove embolic debris, optimizing patient outcomes. Innovations in device design, such as smaller, more flexible triage devices and improved navigation, have improved the effectiveness and ease of use of EPDs. 

Embolic Protection Devices Market Restraints 

Less Skilled People and Skilled Workers  

  • Lack of awareness among healthcare providers and patients, especially in developing regions, hampers the adoption of EPDs. Many healthcare facilities lack the expertise and training necessary to incorporate embolic protection devices effectively during interventional procedures. The limited availability of skilled workers capable of handling these advanced technologies limits their use, especially in rural and underserved regions.  

Increased Costs Associated with EPD and Procedures  

  • The major restraints of the embolic protection devices market are the high cost of these devices and their support system. Advanced EPDs are often more costly, making them more unavailable in low- and middle-income countries. Additionally, the associated procedural costs, including the use of specialized equipment and skilled professionals, further limit their adoption in the resource-constrained settings. This cost barrier presents a challenge to the market, especially in the areas where healthcare costs are low. 

Request Free Customization of this report to help us to meet your business objectives.

Embolic Protection Devices Market Competitive Landscape

The embolic protection devices industry is highly competitive, driven by innovations and technological advancements of established players and emerging companies. Key players like Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Medtronic expand their R&D capabilities in a complex, large distribution network. These companies manage the market with their ideas and have focused on the development of next-generation EPDs that provide improved safety, accuracy, and ease of use. Strategic partnerships and acquisitions play an important role in shaping market dynamics. 

Embolic Protection Devices Market Top Player’s Company Profile

  • Medtronic 
  • Abbott Laboratories 
  • Boston Scientific 
  • Contego Medical 
  • Silk Road Medical 
  • Claret Medical 
  • Allium Medical Solutions 
  • Edwards Lifesciences 
  • Healthcare Solutions Holding, LLC 
  • Innovative Cardiovascular Solutions, LLC 
  • Transverse Medical, Inc. 
  • Keystone Heart Ltd. 
  • InspireMD, Inc. 
  • AngioDynamics, Inc. 
  • Emboline, Inc. 
  • Acandis GmbH & Co. KG 
  • Veryan Medical Ltd. 
  • Shanghai MicroPort Medical Co., Ltd. 
  • MedNova, Inc.

Embolic Protection Devices Market Recent Developments

  • In April 2024, Embolin, Inc. announced the acquisition of SWAT Medical’s embolic protection intellectual property portfolio. The acquisition is expected to expand Emboline's existing platform technology and reduce the risk of infection caused by embolic debris thrown into the bloodstream. 
  • In September 2022, the Boston Science Foundation revealed the results of a clinical trial of PROTECTED TAVR evaluating the SENTINEL brain protection system designed to capture and eliminate embolic debris from the replacement of the transcatheter aortic valve before it can reach the brain and potentially cause a stroke. Such advancements helped to retain the company's brand image while also extending the company's customer portfolio.        
  • In February 2022, Cardiovascular Systems, Inc. initiated a recall of its WIRION Embolic Protection Device due to issues with filter breakage during recovery. 

Embolic Protection Devices Key Market Trends

  • Rising Adoption of Transcatheter Aortic Valve Replacement (TAVR) Techniques: The increasing availability of transcatheter aortic valve replacement (TAVR) techniques has led to a demand for embolic protection devices. TAVR is a relatively safe option for the treatment of aortic valve stenosis, a condition that frequently produces embolic debris during intervention. The use of EPDs in TAVR procedures reduces the risk of stroke and other complications.  
  • Integration of Advanced Technologies in Equipment Manufacturing: The incorporation of advanced technologies, such as enhanced imaging and real-time diagnostic capabilities, is changing the embolic protection devices industry for embolic safety devices. Additionally, the integration of artificial intelligence (AI) into system development and management improves the accuracy of the EPD process, resulting in better outcomes and greater acceptance by health care professionals.  

Embolic Protection Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.   

According to SkyQuest analysis, with the increasing incidence of cardiovascular diseases and advances in minimally invasive techniques, the market for embolic protection devices is expanding rapidly. The high costs and lack of knowledge are a challenge to market growth, especially in areas where limited resources are available. As the worldwide focus on affected person safety and the strategic making plans intensifies, the demand for EPDs is predicted to increase, making them an essential part of cutting-edge interventional cardiology and vascular care. 

Report Metric Details
Growth Rate ong>US Embolic Protection Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

%
Segments covered
  • Type
    • Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices
  • Material
    • Nitinol, Polyurethane
  • Indication
    • Percutaneous Coronary Intervention, Carotid Artery Diseases, Saphenous Vein Graft Disease, Transcatheter Aortic Valve Replacement, Other Indications
  • Application
    • Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases
  • End User
    • Hospitals, Ambulatory Surgical Centers
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Medtronic 
  • Abbott Laboratories 
  • Boston Scientific 
  • Contego Medical 
  • Silk Road Medical 
  • Claret Medical 
  • Allium Medical Solutions 
  • Edwards Lifesciences 
  • Healthcare Solutions Holding, LLC 
  • Innovative Cardiovascular Solutions, LLC 
  • Transverse Medical, Inc. 
  • Keystone Heart Ltd. 
  • InspireMD, Inc. 
  • AngioDynamics, Inc. 
  • Emboline, Inc. 
  • Acandis GmbH & Co. KG 
  • Veryan Medical Ltd. 
  • Shanghai MicroPort Medical Co., Ltd. 
  • MedNova, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Embolic Protection Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Embolic Protection Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Embolic Protection Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Embolic Protection Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Embolic Protection Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Embolic Protection Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

US Embolic Protection Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

The embolic protection devices industry is highly competitive, driven by innovations and technological advancements of established players and emerging companies. Key players like Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Medtronic expand their R&D capabilities in a complex, large distribution network. These companies manage the market with their ideas and have focused on the development of next-generation EPDs that provide improved safety, accuracy, and ease of use. Strategic partnerships and acquisitions play an important role in shaping market dynamics.  'Medtronic ', 'Abbott Laboratories ', 'Boston Scientific ', 'Contego Medical ', 'Silk Road Medical ', 'Claret Medical ', 'Allium Medical Solutions ', 'Edwards Lifesciences ', 'Healthcare Solutions Holding, LLC ', 'Innovative Cardiovascular Solutions, LLC ', 'Transverse Medical, Inc. ', 'Keystone Heart Ltd. ', 'InspireMD, Inc. ', 'AngioDynamics, Inc. ', 'Emboline, Inc. ', 'Acandis GmbH & Co. KG ', 'Veryan Medical Ltd. ', 'Shanghai MicroPort Medical Co., Ltd. ', 'MedNova, Inc.'

Rising Adoption of Transcatheter Aortic Valve Replacement (TAVR) Techniques: The increasing availability of transcatheter aortic valve replacement (TAVR) techniques has led to a demand for embolic protection devices. TAVR is a relatively safe option for the treatment of aortic valve stenosis, a condition that frequently produces embolic debris during intervention. The use of EPDs in TAVR procedures reduces the risk of stroke and other complications.  

As per embolic protection devices market outlook, North America is the dominant region in embolic protective devices market, mainly due to advanced healthcare, high prevalence of cardiovascular diseases and high adoption of minimally invasive procedures. The US especially leads the market with the presence of key players such as Boston Scientific and Abbott Laboratories, who constantly introduce new EPDs. Furthermore, they focused on reducing the burden of cardiovascular diseases driving high demand for EPDs of transcatheter aortic valve replacement (TAVR) procedures and other interventional surgeries. Government policies also contribute to the dominance of the market in the United States. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Embolic Protection Devices Market

Report ID: SQMIG35A2683

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE